Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)

NCT02296580

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States

Center for Neurosciences Tucson, Arizona, United States

cCARE - California Cancer Associates for Research & Excellence Encinitas, California, United States

John Wayne Cancer Institute @ Providecne St. Johns Health Center Santa Monica, California, United States

View all 13 locations

View Trial Details

Completed

Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas

NCT02388659

Conditions: Astrocytoma, Astrocytomas, Glioma, +10 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

NCT01607905

Conditions: Adenocarcinoma, Astrocytoma, Carcinoma, +28 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Karmanos Cancer Institute Detroit, Michigan, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Gabrail Cancer Center Canton, Ohio, United States

View Trial Details

Completed

Nutrition in Gastrointestinal Tumors

NCT04476082

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +42 more
Locations: University Medicine Greifswald Greifswald, Germany

View Trial Details

Completed

Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma

NCT02032810

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

NCT03072134

Conditions: Adenoviridae Infections, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, +26 more
Locations: City of Hope Duarte, California, United States

Northwestern Memorial Hospital Chicago, Illinois, United States

View Trial Details

Completed

Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma

NCT01657591

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas

NCT02829931

Conditions: Glioma, Malignant Glioma, Neoplasms, +6 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

NCT04430842

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations: St George Private Hospital Kogarah, New South Wales, Australia

Sydney Southwest Private Hospital Liverpool, New South Wales, Australia

View Trial Details

Completed

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

NCT01176461

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions